Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Millenson

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Haematologica|December 14, 2004
Phase II study of fludarabine and alpha-interferon in patients with low-grade non-Hodgkin's lymphomaGloria J Morris, Michael M Millenson, Kristin Padavic-Shaller, et al.
Oncoimmunology|August 17, 2017
NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptorsAlexander W MacFarlane, Mowafaq Jillab, Mitchell R Smith, et al.
Stroke|September 1, 1993
Effect of low-intensity warfarin anticoagulation on level of activity of the hemostatic system in patients with atrial fibrillation. BAATAF InvestigatorsJ P Kistler, D E Singer, M M Millenson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 13, 2010
NCCN Task Force: Transfusion and iron overload in patients with myelodysplastic syndromesPeter L Greenberg, Cynthia K Rigsby, Richard M Stone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2008
Comparison of referring and final pathology for patients with non-Hodgkin's lymphoma in the National Comprehensive Cancer NetworkAnn S LaCasce, Michelle E Kho, Jonathan W Friedberg, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 2, 2008
Promising survival in patients with recurrent non-small cell lung cancer treated with docetaxel and gemcitabine in combination as second-line therapyChao Hui Huang, Michael M Millenson, Eric J Sherman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
Phase I study of bryostatin 1 and fludarabine in patients with chronic lymphocytic leukemia and indolent (non-Hodgkin's) lymphomaJohn D Roberts, Mitchell R Smith, Eric J Feldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Phase I trial of multiple cycles of high-dose carboplatin, paclitaxel, and topotecan with peripheral-blood stem-cell support as front-line therapyR J Schilder, J M Gallo, M M Millenson, et al.
Cancer|August 28, 2003
Routine mammography is associated with earlier stage disease and greater eligibility for breast conservation in breast carcinoma patients age 40 years and olderGary M Freedman, Penny R Anderson, Lori J Goldstein, et al.
Oncology (Williston Park, N.Y.)|February 24, 2001
NCCN Practice Guidelines for Acute Myelogenous LeukemiaF R Appelbaum, M R Baer, M H Carabasi, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Haematologica|December 14, 2004
Phase II study of fludarabine and alpha-interferon in patients with low-grade non-Hodgkin's lymphomaGloria J Morris, Michael M Millenson, Kristin Padavic-Shaller, et al.
Oncoimmunology|August 17, 2017
NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptorsAlexander W MacFarlane, Mowafaq Jillab, Mitchell R Smith, et al.
Stroke|September 1, 1993
Effect of low-intensity warfarin anticoagulation on level of activity of the hemostatic system in patients with atrial fibrillation. BAATAF InvestigatorsJ P Kistler, D E Singer, M M Millenson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 13, 2010
NCCN Task Force: Transfusion and iron overload in patients with myelodysplastic syndromesPeter L Greenberg, Cynthia K Rigsby, Richard M Stone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2008
Comparison of referring and final pathology for patients with non-Hodgkin's lymphoma in the National Comprehensive Cancer NetworkAnn S LaCasce, Michelle E Kho, Jonathan W Friedberg, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 2, 2008
Promising survival in patients with recurrent non-small cell lung cancer treated with docetaxel and gemcitabine in combination as second-line therapyChao Hui Huang, Michael M Millenson, Eric J Sherman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
Phase I study of bryostatin 1 and fludarabine in patients with chronic lymphocytic leukemia and indolent (non-Hodgkin's) lymphomaJohn D Roberts, Mitchell R Smith, Eric J Feldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Phase I trial of multiple cycles of high-dose carboplatin, paclitaxel, and topotecan with peripheral-blood stem-cell support as front-line therapyR J Schilder, J M Gallo, M M Millenson, et al.
Cancer|August 28, 2003
Routine mammography is associated with earlier stage disease and greater eligibility for breast conservation in breast carcinoma patients age 40 years and olderGary M Freedman, Penny R Anderson, Lori J Goldstein, et al.
Oncology (Williston Park, N.Y.)|February 24, 2001
NCCN Practice Guidelines for Acute Myelogenous LeukemiaF R Appelbaum, M R Baer, M H Carabasi, et al.
Pageof 5